The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes
original research, editorial comments, review articles and news on experimental oncology, clinical oncology (medical, paediatric, radiation,
surgical), translational oncology, and on cancer epidemiology and prevention. The Journal ... click here for full Aims & Scope
The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes
original research, editorial comments, review articles and news on experimental oncology, clinical oncology (medical, paediatric, radiation,
surgical), translational oncology, and on cancer epidemiology and prevention. The Journal now has online submission for authors. Please
submit manuscripts at 
http://ees.elsevier.com/ejc and follow the instructions on the site.
The European Journal
of Cancer (including EJC Supplements) is the official Journal of the European Organisation for Research and Treatment of Cancer
(EORTC), the European CanCer Organisation (ECCO), the European Association for Cancer Research (EACR), the the European Society of Breast
Cancer Specialists (EUSOMA) and the European School of Oncology (ESO).
Supplements to the European Journal of Cancer are
published under the title EJC Supplements (ISSN 1359-6349). All subscribers to European Journal of Cancer automatically
receive this publication.
To access the latest tables of contents, abstracts and full-text articles from the EJC, including
Articles-in-Press, please visit ScienceDirect.
Hide Aims & Scope
Editor-in-Chief:
John Smyth
To visit the online site go to
European Journal of Cancer Online
We are delighted to announce that the 2008 Impact Factor for the
European Journal of Cancer is 4.475, ranking it 36 out of 141 journals in the Oncology category (courtesy Thomson Reuters, 2008 Journal Citation Reports, Science Edition).
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company